Nexalin Technology (NXL) Short-term Investments (2022 - 2026)
Nexalin Technology's (NXL) quarterly Short-term Investments came in at $1.5 million in Q1 2026, up 5.01% year-on-year from $1.4 million in Q1 2025, and down 51.1% quarter-over-quarter from $3.1 million in Q4 2025.
Nexalin Technology (NXL) Short-term Investments (2022 - 2026) Analysis & Trends
Nexalin Technology's Short-term Investments history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- On a quarterly basis, Short-term Investments rose 5.01% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 5.01% increase from a year earlier, with the FY2025 full-year figure at $3.1 million, up 5.61% from the prior year.
- Short-term Investments eased to $1.5 million in Q1 2026 per NXL's latest filing, from $3.1 million in the prior quarter.
- Across five years, Short-term Investments topped out at $6.8 million in Q4 2022 and bottomed at $1.4 million in Q1 2025.
- The 5-year median for Short-term Investments is $3.6 million (2023), against an average of $3.6 million.
- Biggest YoY gain for Short-term Investments was 26.19% in 2024; the steepest drop was 69.84% in 2024.
- Year by year, Short-term Investments stood at $6.8 million in 2022, then sank by 65.33% to $2.4 million in 2023, then rose by 22.69% to $2.9 million in 2024, then climbed by 5.61% to $3.1 million in 2025, then sank by 51.1% to $1.5 million in 2026.
- Per Business Quant, the three latest NXL Short-term Investments figures stand at $1.5 million (Q1 2026), $3.1 million (Q4 2025), and $3.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Nexalin Technology | 9.44 Mn | 6.73 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 4.51 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 3.58 Mn |
| Jun 30, 2023 | 4.46 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 6.83 Mn |